Back to HomeBeta

ICD-10 Coding for Lymphoproliferative Disorder(D47.Z1, D76.1)

Complete ICD-10-CM coding and documentation guide for Lymphoproliferative Disorder. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Lymphoproliferative DiseaseLymphoid Proliferative Disorder

Related ICD-10 Code Ranges

Complete code families applicable to Lymphoproliferative Disorder

D47.Z1Primary Range

Post-transplant lymphoproliferative disorder

Primary code for PTLD, indicating lymphoproliferative disorder post-transplant.

Malignant neoplasms of lymphoid, hematopoietic and related tissue

Includes various lymphomas and related conditions, relevant for differential diagnosis.

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

Includes Autoimmune Lymphoproliferative Syndrome (ALPS).

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
D47.Z1Post-transplant lymphoproliferative disorderUse for lymphoproliferative disorders occurring post-transplant, confirmed by biopsy.
  • EBV status
  • Transplant history
  • Biopsy confirmation
D76.1Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissueUse for ALPS with confirmed genetic testing and clinical criteria.
  • Double-negative T-cells
  • FAS mutation

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for lymphoproliferative disorder

Essential facts and insights about Lymphoproliferative Disorder

Lymphoproliferative disorder post-transplant is coded as D47.Z1, with additional codes for EBV status and transplant details.

Primary ICD-10-CM Codes for lymphoproliferative disorder

Post-transplant lymphoproliferative disorder
Billable Code

Decision Criteria

clinical Criteria

  • Biopsy-confirmed lymphoproliferative disorder post-transplant

documentation Criteria

  • Document EBV status and transplant details

Applicable To

  • PTLD

Excludes

Clinical Validation Requirements

  • EBV status
  • Transplant history
  • Biopsy confirmation

Code-Specific Risks

  • Incorrect use without transplant history

Coding Notes

  • Ensure documentation includes transplant and EBV status.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Epstein-Barr virus as the cause of diseases classified elsewhere

B97.2
Use to specify EBV involvement in PTLD.

Kidney transplant status

Z94.0
Use to indicate transplant status in PTLD cases.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Non-Hodgkin lymphoma, unspecified

C85.9
Use C85.9 for unspecified NHL not related to transplant.

Hodgkin lymphoma, unspecified

C81.9
Use C81.9 for Hodgkin lymphoma, not ALPS.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Lymphoproliferative Disorder to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code D47.Z1.

Impact

Clinical: Misrepresentation of patient's clinical condition., Regulatory: Non-compliance with coding standards., Financial: Potential claim denials.

Mitigation Strategy

Review transplant history during coding., Ensure all relevant clinical details are documented.

Impact

Reimbursement: Potential denial of claims due to incomplete documentation., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.

Mitigation Strategy

Always document transplant history when using D47.Z1.

Impact

Failure to document transplant status can lead to audit issues.

Mitigation Strategy

Ensure all transplant details are included in patient records.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Lymphoproliferative Disorder, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Lymphoproliferative Disorder

Use these documentation templates to ensure complete and accurate documentation for Lymphoproliferative Disorder. These templates include all required elements for proper coding and billing.

Post-transplant lymphoproliferative disorder

Specialty: Oncology

Required Elements

  • Transplant history
  • EBV status
  • Biopsy results

Examples: Poor vs. Good Documentation

Poor Documentation Example
Patient with PTLD.
Good Documentation Example
Patient with PTLD, EBV+, post-renal transplant. Biopsy confirms B-cell origin.
Explanation
The good example provides specific details necessary for accurate coding and billing.

Need help with ICD-10 coding for Lymphoproliferative Disorder? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more